New report compares U.S. and European funding for research related to synthetic biology

New Report Compares U.S. and European Funding

A new analysis by the Synthetic Biology Project at the Woodrow Wilson Center found that the U.S. government has spent around $430 million on research related to synthetic biology since 2005, with the Department of Energy funding a majority of the research.  By comparison, the analysis indicated that the European Union and three individual European countries – the Netherlands, United Kingdom, and Germany – had spent approximately $160 million during that same period.

Approximately 4 percent of the U.S. funding and 2 percent of the European funding was being spent to explore ethical, legal, and social implications of synthetic biology.  The analysis uncovered no projects dedicated to risk assessment.

"We are releasing the analysis now with the hope that it will lead to further disclosures by government entities concerning the amount and focus of R&D funding in synthetic biology, and better research coordination," said David Rejeski, the Director of the Synthetic Biology Project.  "As that data becomes available, we will update our analysis."

This report follows the announcement, on May 20th by the J.C. Venter Institute, of the creation of a bacterial cell that is controlled by a synthetic genome.  "Though the private sector is active in this field, government investments in synthetic biology are large and increasing," said Dr. Todd Kuiken, who oversaw the analysis.  "A large portion of the U.S. funding is dedicated to biofuels research."